Skip to content
Research Article Open access CC BY 4.0

Detect Drug Interactions with Metronidazole

Ibrahim Dighriri, Ahmed Mobarki, Naif Althomali, Khalid Alqurashi, Othman Daghriri, Bashaer Bin Howimel, Izdihar Alahmad, Rawan Alsaadi, Manar Alsufyani, Manar Balobade, Reem Altemani, Bayader Alatawi, Wejdan Sharoufna, Taif Almuntashiri, Sultan Almushawwah

Journal of Pharmaceutical Research International · pp. 597–604 · Published 28 Oct 2021

10.9734/jpri/2021/v33i47A33049

Abstract

Introduction: Metronidazole has been prescribed to treat infections for over a century and continues to be helpful in the therapy of amoebiasis, trichomoniasis, and giardiasis. Metronidazole is a cost-effective medication because of its low price, few adverse effects, and favorable pharmacokinetic and pharmacodynamic properties; nevertheless, it interacts with a wide variety of other medications. Some interactions with other medicines diminish its effectiveness, while others increase it. Aims: The study aims to detect and evaluate metronidazole interactions with other medicines at King Abdulaziz Specialist Hospital. Methodology: This retrospective study encompasses the review of 360 computerized prescriptions inside the outpatient clinic at King Abdulaziz Specialist Hospital in Saudi Arabia between March and September 2020 to detect and evaluate interactions among metronidazole and different medications. Results: Metronidazole interactions are mostly major or moderate. Metronidazole had the most common interactions with domperidone (15.83 %), famotidine (13.89 %), and ciprofloxacin (11.67 %). Metronidazole contains a nitroimidazole ring, which suppresses the metabolism in the liver of numerous medications, including those that may be metabolized by the CYP3A4 and/or CYP450 2C9 isoenzymes. The combination of metronidazole with phenytoin or phenobarbital can cause metronidazole elimination to be accelerated and phenytoin clearance to be reduced. Metronidazole may improve warfarin's anticoagulant effects, leading to a longer prothrombin time and a higher risk of bleeding. Concurrent use of metronidazole with alfuzosin, escitalopram, and ondansetron may raise the risks of QT-interval prolongation and arrhythmias. Conclusion: Most metronidazole drug interactions can be avoided by following excellent clinical care and clinical pharmacology concepts, such as avoiding complex treatment regimens, educating patients. and identifying patient risk factors. Furthermore, before prescribing and dispensing medicines, physicians and pharmacists should utilize drug-drug interactions checkers such as Micromedex and Lexicomp or a book such as Stockley's Drug Interactions.

Metronidazole drug interaction antibiotic domperidone

Cited by 3

Profil Antibiotik Pasien COVID-19 di RSUD Dr. Moewardi Surakarta

Rini Budi Astuti, Tri Murtati Andayani · Generics: Journal of Research in Pharmacy · 2025

Development of the Composition of Combined Medicinal Pencils for the Treatment of Dental Diseases

I. V. Alekseeva, T. E. Ryumina, V. V. Novikova · Drug development & registration · 2022

Metronidazole—An Old Drug for Structure Optimization and Repurposing

Vasanti Suvarna, Manikanta Murahari, Shrutee Pawar · Chemistry & Biodiversity · 2025

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

3

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.